Antibacterial medicine sales in Austria stood at 52.4 Million US Dollars in 2023. Over the past decade, there has been a noticeable downward trend with significant variations. The highest recorded value was in 2013, with 92.6 Million US Dollars, which has steadily declined annually.
Year-on-year analysis from the past two years indicates a slight recovery in 2022 with a 10.12% increase. However, 2023 saw a decrease of 3.68%. The compound annual growth rate (CAGR) over the last five years shows a decline of approximately 5.25%.
Looking ahead, the forecast from 2024 to 2028 projects an accelerated decline, with a negative 5-year CAGR of 7.32% and an overall growth rate decrease of 31.61% by 2028.
Future trends to watch for may include policy changes impacting antibiotic usage, shifts in healthcare practices towards alternative treatments, and technological advancements in medication that could influence market dynamics.
